Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/ofid/ofv179 http://scihub22266oqcxt.onion/10.1093/ofid/ofv179 C4685151!4685151!26693494     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Open+Forum+Infect+Dis 2015 ; 2 (4): ä Nephropedia Template TP {{tp|p=26693494|t=2015. Regulatory Solutions to the Problem of High Generic Drug Costs |pdf=|usr=}}{{26693494}} gab.com Text Regulatory Solutions to the Problem of High Generic Drug Costs JO: Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=26693494 #FOAvip Recent reports have highlighted dramatic price increases for several older generic drugs, including a number of essential products used to treat deadly infectious diseases. Although most of these medicines have been widely available at reasonable prices for decades, some manufacturers have seized on unique features of the pharmaceutical marketplace to seek substantial profits. In this Perspective, we examine limitations in current price regulation among public and private payors and consider several reforms that could address the problem of expensive generic drugs through improved competition. Twit Text FOAVip Regulatory Solutions to the Problem of High Generic Drug Costs ????Open Forum Infect Dis http://www.kidney.de/pget.php?&tw=1&pmid=26693494 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26693494 #FOAvip English Wikipedia <ref>{{Cite pmid|26693494}}</ref> Regulatory Solutions to the Problem of High Generic Drug Costs #MMPMID26693494 Luo J; Sarpatwari A; Kesselheim AS Open Forum Infect Dis 2015[Dec]; 2 (4): ä PMID26693494show ga Recent reports have highlighted dramatic price increases for several older generic drugs, including a number of essential products used to treat deadly infectious diseases. Although most of these medicines have been widely available at reasonable prices for decades, some manufacturers have seized on unique features of the pharmaceutical marketplace to seek substantial profits. In this Perspective, we examine limitations in current price regulation among public and private payors and consider several reforms that could address the problem of expensive generic drugs through improved competition. äRegulatory Solutions to the Problem of High Generic Drug Costs (epmc).pdf DeepDyve Pubget Overpricing